Global Influenza Vaccination Market Growth (Status and Outlook) 2022-2028
- LP 4809379
- 103 Pages
- February 2022
- Pharmaceuticals
The United States Influenza Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Influenza Vaccination market, reaching US$ million by the year 2028. As for the Europe Influenza Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Influenza Vaccination players cover Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), and Novartis (Europe), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccination market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Egg Based
Cell Culture
Recombinant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Research Organizations
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccination Market Size 2017-2028
2.1.2 Influenza Vaccination Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Influenza Vaccination Segment by Type
2.2.1 Egg Based
2.2.2 Cell Culture
2.2.3 Recombinant
2.3 Influenza Vaccination Market Size by Type
2.3.1 Influenza Vaccination Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Influenza Vaccination Market Size Market Share by Type (2017-2022)
2.4 Influenza Vaccination Segment by Application
2.4.1 Hospitals
2.4.2 Research Organizations
2.5 Influenza Vaccination Market Size by Application
2.5.1 Influenza Vaccination Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Influenza Vaccination Market Size Market Share by Application (2017-2022)
3 Influenza Vaccination Market Size by Player
3.1 Influenza Vaccination Market Size Market Share by Players
3.1.1 Global Influenza Vaccination Revenue by Players (2020-2022)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2020-2022)
3.2 Global Influenza Vaccination Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Influenza Vaccination by Regions
4.1 Influenza Vaccination Market Size by Regions (2017-2022)
4.2 Americas Influenza Vaccination Market Size Growth (2017-2022)
4.3 APAC Influenza Vaccination Market Size Growth (2017-2022)
4.4 Europe Influenza Vaccination Market Size Growth (2017-2022)
4.5 Middle East & Africa Influenza Vaccination Market Size Growth (2017-2022)
5 Americas
5.1 Americas Influenza Vaccination Market Size by Country (2017-2022)
5.2 Americas Influenza Vaccination Market Size by Type (2017-2022)
5.3 Americas Influenza Vaccination Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccination Market Size by Region (2017-2022)
6.2 APAC Influenza Vaccination Market Size by Type (2017-2022)
6.3 APAC Influenza Vaccination Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza Vaccination by Country (2017-2022)
7.2 Europe Influenza Vaccination Market Size by Type (2017-2022)
7.3 Europe Influenza Vaccination Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccination by Region (2017-2022)
8.2 Middle East & Africa Influenza Vaccination Market Size by Type (2017-2022)
8.3 Middle East & Africa Influenza Vaccination Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Influenza Vaccination Market Forecast
10.1 Global Influenza Vaccination Forecast by Regions (2023-2028)
10.1.1 Global Influenza Vaccination Forecast by Regions (2023-2028)
10.1.2 Americas Influenza Vaccination Forecast
10.1.3 APAC Influenza Vaccination Forecast
10.1.4 Europe Influenza Vaccination Forecast
10.1.5 Middle East & Africa Influenza Vaccination Forecast
10.2 Americas Influenza Vaccination Forecast by Country (2023-2028)
10.2.1 United States Influenza Vaccination Market Forecast
10.2.2 Canada Influenza Vaccination Market Forecast
10.2.3 Mexico Influenza Vaccination Market Forecast
10.2.4 Brazil Influenza Vaccination Market Forecast
10.3 APAC Influenza Vaccination Forecast by Region (2023-2028)
10.3.1 China Influenza Vaccination Market Forecast
10.3.2 Japan Influenza Vaccination Market Forecast
10.3.3 Korea Influenza Vaccination Market Forecast
10.3.4 Southeast Asia Influenza Vaccination Market Forecast
10.3.5 India Influenza Vaccination Market Forecast
10.3.6 Australia Influenza Vaccination Market Forecast
10.4 Europe Influenza Vaccination Forecast by Country (2023-2028)
10.4.1 Germany Influenza Vaccination Market Forecast
10.4.2 France Influenza Vaccination Market Forecast
10.4.3 UK Influenza Vaccination Market Forecast
10.4.4 Italy Influenza Vaccination Market Forecast
10.4.5 Russia Influenza Vaccination Market Forecast
10.5 Middle East & Africa Influenza Vaccination Forecast by Region (2023-2028)
10.5.1 Egypt Influenza Vaccination Market Forecast
10.5.2 South Africa Influenza Vaccination Market Forecast
10.5.3 Israel Influenza Vaccination Market Forecast
10.5.4 Turkey Influenza Vaccination Market Forecast
10.5.5 GCC Countries Influenza Vaccination Market Forecast
10.6 Global Influenza Vaccination Forecast by Type (2023-2028)
10.7 Global Influenza Vaccination Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Information
11.1.2 Abbott (U.S.) Influenza Vaccination Product Offered
11.1.3 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott (U.S.) Main Business Overview
11.1.5 Abbott (U.S.) Latest Developments
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Information
11.2.2 AstraZeneca (Europe) Influenza Vaccination Product Offered
11.2.3 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AstraZeneca (Europe) Main Business Overview
11.2.5 AstraZeneca (Europe) Latest Developments
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Information
11.3.2 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Offered
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 BioCryst Pharmaceuticals (U.S.) Main Business Overview
11.3.5 BioCryst Pharmaceuticals (U.S.) Latest Developments
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Information
11.4.2 Novartis (Europe) Influenza Vaccination Product Offered
11.4.3 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis (Europe) Main Business Overview
11.4.5 Novartis (Europe) Latest Developments
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Information
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Offered
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Main Business Overview
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Latest Developments
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Information
11.6.2 GlaxoSmithKline (Europe) Influenza Vaccination Product Offered
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 GlaxoSmithKline (Europe) Main Business Overview
11.6.5 GlaxoSmithKline (Europe) Latest Developments
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Information
11.7.2 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Offered
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Hualan Biological Engineering (Asia Pacific) Main Business Overview
11.7.5 Hualan Biological Engineering (Asia Pacific) Latest Developments
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Information
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Offered
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Main Business Overview
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Latest Developments
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Information
11.9.2 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Offered
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 F. Hoffmann-La Roche (Europe) Main Business Overview
11.9.5 F. Hoffmann-La Roche (Europe) Latest Developments
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Information
11.10.2 Sanofi (Europe) Influenza Vaccination Product Offered
11.10.3 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sanofi (Europe) Main Business Overview
11.10.5 Sanofi (Europe) Latest Developments
12 Research Findings and Conclusion
Table 1. Influenza Vaccination Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Egg Based
Table 3. Major Players of Cell Culture
Table 4. Major Players of Recombinant
Table 5. Influenza Vaccination Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Influenza Vaccination Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Influenza Vaccination Market Size Market Share by Type (2017-2022)
Table 8. Influenza Vaccination Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Influenza Vaccination Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Influenza Vaccination Market Size Market Share by Application (2017-2022)
Table 11. Global Influenza Vaccination Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Influenza Vaccination Revenue Market Share by Player (2020-2022)
Table 13. Influenza Vaccination Key Players Head office and Products Offered
Table 14. Influenza Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Influenza Vaccination Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Influenza Vaccination Market Size Market Share by Regions (2017-2022)
Table 19. Americas Influenza Vaccination Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Influenza Vaccination Market Size Market Share by Country (2017-2022)
Table 21. Americas Influenza Vaccination Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Influenza Vaccination Market Size Market Share by Type (2017-2022)
Table 23. Americas Influenza Vaccination Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Influenza Vaccination Market Size Market Share by Application (2017-2022)
Table 25. APAC Influenza Vaccination Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Influenza Vaccination Market Size Market Share by Region (2017-2022)
Table 27. APAC Influenza Vaccination Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Influenza Vaccination Market Size Market Share by Type (2017-2022)
Table 29. APAC Influenza Vaccination Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Influenza Vaccination Market Size Market Share by Application (2017-2022)
Table 31. Europe Influenza Vaccination Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Influenza Vaccination Market Size Market Share by Country (2017-2022)
Table 33. Europe Influenza Vaccination Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Influenza Vaccination Market Size Market Share by Type (2017-2022)
Table 35. Europe Influenza Vaccination Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Influenza Vaccination Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Influenza Vaccination Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Influenza Vaccination Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Influenza Vaccination Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Influenza Vaccination Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Influenza Vaccination Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Influenza Vaccination Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Influenza Vaccination
Table 44. Key Market Challenges & Risks of Influenza Vaccination
Table 45. Key Industry Trends of Influenza Vaccination
Table 46. Global Influenza Vaccination Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Influenza Vaccination Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Influenza Vaccination Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Influenza Vaccination Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Influenza Vaccination Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Influenza Vaccination Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott (U.S.) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 53. Abbott (U.S.) Influenza Vaccination Product Offered
Table 54. Abbott (U.S.) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott (U.S.) Main Business
Table 56. Abbott (U.S.) Latest Developments
Table 57. AstraZeneca (Europe) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 58. AstraZeneca (Europe) Influenza Vaccination Product Offered
Table 59. AstraZeneca (Europe) Main Business
Table 60. AstraZeneca (Europe) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. AstraZeneca (Europe) Latest Developments
Table 62. BioCryst Pharmaceuticals (U.S.) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 63. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Offered
Table 64. BioCryst Pharmaceuticals (U.S.) Main Business
Table 65. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. BioCryst Pharmaceuticals (U.S.) Latest Developments
Table 67. Novartis (Europe) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 68. Novartis (Europe) Influenza Vaccination Product Offered
Table 69. Novartis (Europe) Main Business
Table 70. Novartis (Europe) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis (Europe) Latest Developments
Table 72. DAIICHI SANKYO COMPANY (Asia Pacific) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 73. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Offered
Table 74. DAIICHI SANKYO COMPANY (Asia Pacific) Main Business
Table 75. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. DAIICHI SANKYO COMPANY (Asia Pacific) Latest Developments
Table 77. GlaxoSmithKline (Europe) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 78. GlaxoSmithKline (Europe) Influenza Vaccination Product Offered
Table 79. GlaxoSmithKline (Europe) Main Business
Table 80. GlaxoSmithKline (Europe) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. GlaxoSmithKline (Europe) Latest Developments
Table 82. Hualan Biological Engineering (Asia Pacific) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 83. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Offered
Table 84. Hualan Biological Engineering (Asia Pacific) Main Business
Table 85. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Hualan Biological Engineering (Asia Pacific) Latest Developments
Table 87. Mitsubishi Tanabe Pharma (Asia Pacific) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 88. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Offered
Table 89. Mitsubishi Tanabe Pharma (Asia Pacific) Main Business
Table 90. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Mitsubishi Tanabe Pharma (Asia Pacific) Latest Developments
Table 92. F. Hoffmann-La Roche (Europe) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 93. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Offered
Table 94. F. Hoffmann-La Roche (Europe) Main Business
Table 95. F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. F. Hoffmann-La Roche (Europe) Latest Developments
Table 97. Sanofi (Europe) Details, Company Type, Influenza Vaccination Area Served and Its Competitors
Table 98. Sanofi (Europe) Influenza Vaccination Product Offered
Table 99. Sanofi (Europe) Main Business
Table 100. Sanofi (Europe) Influenza Vaccination Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Sanofi (Europe) Latest Developments
List of Figures
Figure 1. Influenza Vaccination Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Influenza Vaccination Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Influenza Vaccination Market Size Market Share by Type in 2021
Figure 7. Influenza Vaccination in Hospitals
Figure 8. Global Influenza Vaccination Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Influenza Vaccination in Research Organizations
Figure 10. Global Influenza Vaccination Market: Research Organizations (2017-2022) & ($ Millions)
Figure 11. Global Influenza Vaccination Market Size Market Share by Application in 2021
Figure 12. Global Influenza Vaccination Revenue Market Share by Player in 2021
Figure 13. Global Influenza Vaccination Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Influenza Vaccination Market Size 2017-2022 ($ Millions)
Figure 15. APAC Influenza Vaccination Market Size 2017-2022 ($ Millions)
Figure 16. Europe Influenza Vaccination Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Influenza Vaccination Market Size 2017-2022 ($ Millions)
Figure 18. Americas Influenza Vaccination Value Market Share by Country in 2021
Figure 19. Americas Influenza Vaccination Consumption Market Share by Type in 2021
Figure 20. Americas Influenza Vaccination Market Size Market Share by Application in 2021
Figure 21. United States Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Influenza Vaccination Market Size Market Share by Region in 2021
Figure 26. APAC Influenza Vaccination Market Size Market Share by Application in 2021
Figure 27. China Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Influenza Vaccination Market Size Market Share by Country in 2021
Figure 34. Europe Influenza Vaccination Market Size Market Share by Type in 2021
Figure 35. Europe Influenza Vaccination Market Size Market Share by Application in 2021
Figure 36. Germany Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Influenza Vaccination Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Influenza Vaccination Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Influenza Vaccination Market Size Market Share by Application in 2021
Figure 44. Egypt Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Influenza Vaccination Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 50. APAC Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 51. Europe Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 53. United States Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 54. Canada Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 57. China Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 58. Japan Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 59. Korea Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 61. India Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 62. Australia Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 63. Germany Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 64. France Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 65. UK Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 66. Italy Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 67. Russia Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 68. Spain Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 71. Israel Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Influenza Vaccination Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Influenza Vaccination Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
